Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-37.64%
operating margin TTM
-25.86%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -145.11 |
| peg ratio | -2.94 |
| price to book ratio | 32.90 |
| price to sales ratio | 433.52 |
| enterprise value multiple | -1,783.51 |
| price fair value | 32.90 |
profitability ratios | |
|---|---|
| gross profit margin | 95.15% |
| operating profit margin | -25.86% |
| pretax profit margin | -33.71% |
| net profit margin | -37.64% |
| return on assets | -11.01% |
| return on equity | -30.05% |
| return on capital employed | -8.31% |
liquidity ratios | |
|---|---|
| current ratio | 10.71 |
| quick ratio | 10.54 |
| cash ratio | 8.55 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 386.30 |
| operating cycle | 575.54 |
| days of payables outstanding | 154.04 |
| cash conversion cycle | 421.50 |
| receivables turnover | 1.93 |
| payables turnover | 2.37 |
| inventory turnover | 0.94 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.43 |
| debt equity ratio | 0.88 |
| long term debt to capitalization | 0.47 |
| total debt to capitalization | 0.47 |
| interest coverage | -1.17 |
| cash flow to debt ratio | -0.30 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.85 |
| cash per share | 5.11 |
| operating cash flow per share | -0.85 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.30 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -147.93 |
Frequently Asked Questions
When was the last time Verona Pharma plc (NASDAQ:VRNA) reported earnings?
Verona Pharma plc (VRNA) published its most recent earnings results on 06-08-2025.
What is Verona Pharma plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Verona Pharma plc (NASDAQ:VRNA)'s trailing twelve months ROE is -30.05%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Verona Pharma plc (VRNA) currently has a ROA of -11.01%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VRNA's net profit margin stand at?
VRNA reported a profit margin of -37.64% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VRNA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.71 in the most recent quarter. The quick ratio stood at 10.54, with a Debt/Eq ratio of 0.88.